Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03176004 · ClinicalTrials.gov registry record · NA

Attention Training to Modify Error-related Negativity and Risk for Anxiety in Adolescence

A NA study of Anxiety, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
600
Enrollment target
2
Study locations

NCT03176004 is a NA study of Anxiety that has completed, run by Florida State University. The registered enrollment target is 600 participants, above the 438-participant average among 364 other Anxiety trials with a reported enrollment target (37% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03176004, a NA study of Anxiety, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
600 participants
Enrollment target
2
Study locations

Study Summary

This is a multi-site study to examine error-related brain activity (i.e., the error-related negativity) and anxiety symptoms in 11 to 14 year-olds (N=600) at two time points separated by two years. The study examines the degree to which error-related negativity can predict anxiety prospectively over two years, and whether a computerized game that alters attention to threat can alter error-related negativity and trajectories of anxiety.

Conditions Studied

Interventions

  • OTHER Attention Bias Modification

Study Locations (2)

California

  • San Diego State University - San Diego

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2016-10
Est. Completion 2021-12-01
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT03176004

The ClinicalTrials.gov registry entry for NCT03176004 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 438-participant average among 364 other Anxiety trials with a reported enrollment target (37% higher). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Attention Bias Modification is the first listed.

NCT03176004 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Florida.

Frequently Asked Questions

What is clinical trial NCT03176004 about?

NCT03176004 is a clinical study titled "Attention Training to Modify Error-related Negativity and Risk for Anxiety in Adolescence". This is a multi-site study to examine error-related brain activity (i.e., the error-related negativity) and anxiety symptoms in 11 to 14 year-olds (N=600) at two time points separated by two years. The study examines the degree to which error-related negativity can predict anxiety prospectively over...

What is the current status of trial NCT03176004?

This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2016-10. Estimated completion is 2021-12-01.

What conditions does trial NCT03176004 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT03176004?

The interventions under investigation include: Attention Bias Modification (OTHER).

Who is sponsoring clinical trial NCT03176004?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03176004 being conducted?

This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.